Skip to main content

Find Clinical Trials

Home
Conditions
Essential Hypertension

Clinical trial condition

Essential Hypertension

Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.

369 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Essential Hypertension trial results

Completed

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

NCT01237223

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Investigative Site Aichi, Japan

Investigative Site Ehime, Japan

Investigative Site Fukuoka, Japan

Investigative Site Hokkaido, Japan

View Trial Details

Completed

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

NCT01127139

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Site Reference ID/Investigator# 44896 Babice, Czechia

Site Reference ID/Investigator# 40910 Beroun, Czechia

Site Reference ID/Investigator# 40908 Bílovec, Czechia

Site Reference ID/Investigator# 38816 Blansko, Czechia

View all 134 locations

View Trial Details

Completed

Intensive Vasodilator Therapy in Patients With Essential Hypertension

NCT01180413

Conditions: Cardiovascular Diseases, Essential Hypertension, High Blood Pressure, +2 more
Locations: Aarhus University Hospital - dept. cardiology (A) Aarhus, Denmark

View Trial Details

Completed

Hybrid Blood Pressure Monitor Validation

NCT01120990

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Hypertension Center, Third Department of Medicine, University of Athens, Greece Athens, Greece

View Trial Details

Completed

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Novartis Investigative Site Aire Sur Adour, France

Novartis Investigative Site Amboise, France

Novartis Investigative Site Angers, France

Novartis Investigative Site Anzin, France

View all 98 locations

View Trial Details

Completed

Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00846365

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Birmingham, Alabama, United States

Haleyville, Alabama, United States

Hueytown, Alabama, United States

Jasper, Alabama, United States

View all 80 locations

View Trial Details

Completed

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

NCT00135551

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Essential Hypertension, +2 more
Locations: Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan

View Trial Details

Completed

Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension

NCT01527760

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Fr Muller Homoeopathic Medical College Hospital Mangalore, Karnataka, India

View Trial Details

Completed

Nijmegen Antihypertensive Management Improvement Study

NCT00457483

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +2 more
Locations: Nijmegen monitoring project coordinated from Nijmegen Nijmegen, Netherlands

View Trial Details

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension

NCT00818883

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations: Birmingham, Alabama, United States

Gulf Shores, Alabama, United States

Scottsboro, Alabama, United States

Gilbert, Arizona, United States

View all 53 locations

View Trial Details